Ana Ribeiro
Associate Director Immunocore Ltd
Dr Ribeiro is a Research Associate Director at Immunocore, leading a team responsible for the
generation of preclinical efficacy and safety data from early stages of drug screening up to
candidate nomination and follow up IND/CTA-enabling studies. She has deep knowledge in I
mmunology and T cell biology, and over 15 years of experience in Research, including pipeline
programme leadership. Dr Ribeiro holds a PhD in Biomedical Sciences from University of Porto,
Portugal, studying T cell and thymus development.
Seminars
Thursday 10th December 2026
CD1a-Targeted PD-1 Agonists for Localised Immunosuppression in Atopic Dermatitis
11:30 am
- IMC-U120AI is a novel, first in class skin targeted PD-1 agonist bispecific (ImmTAI) to provide localised immune inhibition for the treatment of Atopic Dermatitis
- CD1a-targeted PD-1 agonists show potent inhibition of CD4+T-cells and NK cells
- IMC-U120AI is the first Immunocore ‘universal’ therapy
